EUVIMEDEUVIMED entdecken
Crossref

Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes

A. M. Bock, R. Mwangi, Y. Wang, A. Khurana, M. J. Maurer, A. Ayers, B. Kahl, P. Martin, J. Cohen, C. Casulo, I. Lossos, U. Farooq und 7 weitere

Hematological Oncology · 2023-06 · 41 (S2) · 430-432

DOI: 10.1002/hon.3164_317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 09.06.2023. Verfasst von A. M. Bock und 18 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bock, A. M., Mwangi, R., Wang, Y., Khurana, A., Maurer, M. J., Ayers, A., Kahl, B., Martin, P., Cohen, J., Casulo, C., Lossos, I., Farooq, U., Ayyappan, S., Reicks, T., Habermann, T. M., Flowers, C. R., Cerhan, J. R., Nastoupil, L. J., & Nowakowski, G. S. (2023). Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes. Hematological Oncology, 41(S2), 430-432. https://doi.org/10.1002/hon.3164_317

Vancouver

Bock AM, Mwangi R, Wang Y, Khurana A, Maurer MJ, Ayers A, et al. Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes. Hematological Oncology. 2023;41(S2):430-432. doi:10.1002/hon.3164_317

BibTeX
@article{Bock2023,
  author = {Bock, A. M. and Mwangi, R. and Wang, Y. and Khurana, A. and Maurer, M. J. and Ayers, A. and Kahl, B. and Martin, P. and Cohen, J. and Casulo, C. and Lossos, I. and Farooq, U. and Ayyappan, S. and Reicks, T. and Habermann, T. M. and Flowers, C. R. and Cerhan, J. R. and Nastoupil, L. J. and Nowakowski, G. S.},
  title = {Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes},
  journal = {Hematological Oncology},
  year = {2023},
  volume = {41},
  number = {S2},
  pages = {430--432},
  doi = {10.1002/hon.3164_317}
}
Kostenlos starten →